XOMA Royalty Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, XOMA Royalty Corporation Common Stock (XOMA) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 0.9%, relative volume 3.81×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 85, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
XOMA is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $13M notional. Top 3 carry $24M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $13M |
| IWMiShares Russell 2000 ETF | 0.01% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XOMA Jan avg: 3.99% median: 4.60% win: 75% σ: 6.29% n: 4 2022-04-12 → 2026-05-29 | XOMA Feb avg: 2.85% median: 2.19% win: 50% σ: 15.05% n: 4 2022-04-12 → 2026-05-29 | XOMA Mar avg: 2.20% median: -0.93% win: 25% σ: 14.77% n: 4 2022-04-12 → 2026-05-29 | XOMA Apr avg: 3.78% median: 5.36% win: 60% σ: 22.86% n: 5 2022-04-12 → 2026-05-29 | XOMA May avg: -1.24% median: 1.78% win: 60% σ: 4.83% n: 5 2022-04-12 → 2026-05-29 | XOMA Jun avg: 6.78% median: 6.45% win: 75% σ: 13.03% n: 4 2022-04-12 → 2026-05-29 (current) | XOMA Jul avg: 0.14% median: 2.10% win: 50% σ: 12.59% n: 4 2022-04-12 → 2026-05-29 | XOMA Aug avg: 3.36% median: -0.84% win: 50% σ: 21.06% n: 4 2022-04-12 → 2026-05-29 | XOMA Sep avg: -0.05% median: -4.49% win: 50% σ: 13.39% n: 4 2022-04-12 → 2026-05-29 | XOMA Oct avg: 6.47% median: 3.26% win: 50% σ: 21.88% n: 4 2022-04-12 → 2026-05-29 | XOMA Nov avg: 3.69% median: 4.09% win: 50% σ: 20.78% n: 4 2022-04-12 → 2026-05-29 | XOMA Dec avg: -6.78% median: -15.16% win: 25% σ: 21.23% n: 4 2022-04-12 → 2026-05-29 |